Additionally, our analysis of the METABRIC breast cancer dataset showed that patients with NF1 shallow deletions are 1.65 times more likely to die within the first 10 years compared to patients with diploid NF1 status (Dischinger et al., 2018). Here, NF1 is linked to breast cancer.